EX-10.95 2 d402656dex1095.htm AMENDED & RESTATED LICENSE AGREEMENT Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. AMENDED AND RESTATED LICENSE AGREEMENT dated August 6, 2012 by and between ALFA...License Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020
Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. AMENDED AND RESTATED LICENSE AGREEMENT dated August 6, 2012 by and between ALFA WASSERMANN S.P.A. and SALIX PHARMACEUTICALS, INC.License Agreement • November 8th, 2012 • Salix Pharmaceuticals LTD • Pharmaceutical preparations
Contract Type FiledNovember 8th, 2012 Company IndustryAMENDED AND RESTATED LICENSE AGREEMENT (this “Agreement”) dated August 6, 2012 (the “Amendment Effective Date”) by and between Alfa Wassermann S.p.A., a corporation incorporated under the laws of Italy (“Alfa”), and Salix Pharmaceuticals, Inc., a corporation incorporated under the laws of the State of California, United States of America (“Salix”) (each, a “Party” and, collectively, the “Parties”).